263 related articles for article (PubMed ID: 29908359)
1. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection.
El Kamari V; Hileman CO; Gholam PM; Kulkarni M; Funderburg N; McComsey GA
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):536-542.e1. PubMed ID: 29908359
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
Longenecker CT; Hileman CO; Funderburg NT; McComsey GA
Clin Infect Dis; 2014 Oct; 59(8):1148-56. PubMed ID: 25015912
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
[TBL] [Abstract][Full Text] [Related]
4. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
Eckard AR; Jiang Y; Debanne SM; Funderburg NT; McComsey GA
J Infect Dis; 2014 Apr; 209(8):1156-64. PubMed ID: 24415784
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.
Erlandson KM; Jiang Y; Debanne SM; McComsey GA
Clin Infect Dis; 2015 Nov; 61(10):1566-72. PubMed ID: 26157049
[TBL] [Abstract][Full Text] [Related]
6. Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.
Morrison JT; Longenecker CT; Mittelsteadt A; Jiang Y; Debanne SM; McComsey GA
HIV Clin Trials; 2016 Jul; 17(4):140-6. PubMed ID: 27294339
[TBL] [Abstract][Full Text] [Related]
7. Effect of statin on arginine metabolites in treated HIV-infection.
Dirajlal-Fargo S; El Kamari V; Sattar A; Alam K; Funderburg N; Labbato D; Pirro L; Longenecker CT; Wilson WH; McComsey GA
Atherosclerosis; 2017 Nov; 266():74-80. PubMed ID: 28992467
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
Longenecker CT; Sattar A; Gilkeson R; McComsey GA
AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
[TBL] [Abstract][Full Text] [Related]
9. Effects of 96 Weeks of Rosuvastatin on Bone, Muscle, and Fat in HIV-Infected Adults on Effective Antiretroviral Therapy.
Erlandson KM; Jiang Y; Debanne SM; McComsey GA
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):311-6. PubMed ID: 26477698
[TBL] [Abstract][Full Text] [Related]
10. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
11. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
Dirajlal-Fargo S; Kinley B; Jiang Y; Longenecker CT; Hileman CO; Debanne S; McComsey GA
AIDS; 2015 Jan; 29(3):313-21. PubMed ID: 25686680
[TBL] [Abstract][Full Text] [Related]
12. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients.
Calza L; Vanino E; Salvadori C; Manfredi R; Colangeli V; Cascavilla A; Di Bari MA; Motta R; Viale P
HIV Clin Trials; 2014; 15(1):1-13. PubMed ID: 24518210
[TBL] [Abstract][Full Text] [Related]
14. Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults.
Hileman CO; Dirajlal-Fargo S; Lam SK; Kumar J; Lacher C; Combs GF; McComsey GA
J Nutr; 2015 Oct; 145(10):2293-9. PubMed ID: 26269240
[TBL] [Abstract][Full Text] [Related]
15. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
[TBL] [Abstract][Full Text] [Related]
16. Maraviroc for previously treated patients with R5 HIV-1 infection.
Gulick RM; Lalezari J; Goodrich J; Clumeck N; DeJesus E; Horban A; Nadler J; Clotet B; Karlsson A; Wohlfeiler M; Montana JB; McHale M; Sullivan J; Ridgway C; Felstead S; Dunne MW; van der Ryst E; Mayer H;
N Engl J Med; 2008 Oct; 359(14):1429-41. PubMed ID: 18832244
[TBL] [Abstract][Full Text] [Related]
17. Effect of Pericardial Fat Volume and Density on Markers of Insulin Resistance and Inflammation in Patients With Human Immunodeficiency Virus Infection.
Longenecker CT; Margevicius S; Liu Y; Schluchter MD; Yun CH; Bezerra HG; McComsey GA
Am J Cardiol; 2017 Oct; 120(8):1427-1433. PubMed ID: 28822563
[TBL] [Abstract][Full Text] [Related]
18. The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
Rasmussen TA; McMahon JH; Chang JJ; Audsley J; Rhodes A; Tennakoon S; Dantanarayana A; Spelman T; Schmidt T; Kent SJ; Morcilla V; Palmer S; Elliott JH; Lewin SR
Lancet HIV; 2018 May; 5(5):e221-e230. PubMed ID: 29643011
[TBL] [Abstract][Full Text] [Related]
19. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
Hileman CO; Tangpricha V; Sattar A; McComsey GA
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):539-547. PubMed ID: 28045766
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial.
Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A
HIV Med; 2016 Sep; 17(8):605-14. PubMed ID: 26987376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]